Drug Type Small molecule drug |
Synonyms LY 2452473/tadalafil, LY2452473/tadalafil, tadalafil/LY 2452473 + [2] |
Target |
Action modulators, inhibitors |
Mechanism AR modulators(Androgen Receptor modulators), PDE5A inhibitors(Phosphodiesterase 5A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H19N3O4 |
InChIKeyWOXKDUGGOYFFRN-IIBYNOLFSA-N |
CAS Registry171596-29-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erectile Dysfunction | Phase 1 | United States | 01 Jul 2011 |